New data indicating underreporting of federal funding in academic biomedical patents highlight the pressing need for greater transparency under the Bayh-Dole Act.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Bayh, B. US Senate Report of the Committee on the Judiciary on S.414 (US Government Printing Office, 1979).
35 USC Sections 202 (c)(1), (5) (reporting obligations); Section 202(c)(4), 203(a) (retained government rights).
Rai, A.K. & Eisenberg, R.S. Law Contemp. Probl. 66, 289–314 (2003).
Rai, A.K., Allison, J. & Sampat, B. North Carolina L. Rev. 87, 101–115 (2009).
Ewing, T. & Feldman, R. Stan. Tech. L. Rev. 2012, 1–47 (2012).
Smith, M. Inside Higher Ed, May 17, 2012. http://www.insidehighered.com/news/2012/05/17/higher-ed-split-merits-patent-company-intellectual-ventures
Government Accountability Office. Technology Transfer: Agencies' Rights to Federally Funded Inventions (GAO, 2003).
563 US __ (2011).
Brief for United States as Amicus Curiae, Stanford v. Roche. available at http://www.justice.gov/osg/briefs/2010/2pet/6invit/2009-1159.pet.ami.inv.pdf
National Academies of Science. Managing University Intellectual Property in the Public Interest Merrill, S.A. & Mazza, A-M. (eds) (NAS, 2010).
35 USC Section 273 (e)(5).
Government Accountability Office, Technology Transfer: Reporting Requirements for Federally Sponsored Invention Need Revision (GAO, 1999).
Central Admixture Pharmacy Inc. v. Advanced Cardiac Solutions, P.C. 482 F.3d 1347 (Fed. Cir. 2007).
35 USC 203(a).
Eisenberg, R. & Rai, A. Proprietary considerations. in 2 Handbook of Stem Cells: Embryonic Stem Cells (ed., Lanza, R.P.) 793–798 (Elsevier Academic, 2004).
Azoulay, P.R., Michigan, R. & Sampat, B.N. New Engl. J. Med. 357, 2049 (2007).
Sampat, B.N. & Lichtenberg, F.R. Health Affairs 30, 332–339 (2011).
35 USC 201(e).
35 USC 202(c)(5).
37 CFR 401.14(h).
441 US 281 (1979).
Acknowledgements
Research reported in this publication was supported by the National Human Genome Research Institute of the US National Institutes of Health under Award Number P50HG003391. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Human Genome Research Institute or the US National Institutes of Health.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Rai, A., Sampat, B. Accountability in patenting of federally funded research. Nat Biotechnol 30, 953–956 (2012). https://doi.org/10.1038/nbt.2382
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt.2382
This article is cited by
-
Comparing efficiency of patent production between US institutions using a hybrid NIH–USPTO dataset
Nature Biotechnology (2023)
-
Mobility, retention and productivity of genomics scientists in the United States
Nature Biotechnology (2014)